Location History:
- Virum, DE (2013)
- Virum, DK (2008 - 2016)
Company Filing History:
Years Active: 2008-2016
Title: The Innovations of Thomas Børglum Kjeldsen
Introduction
Thomas Børglum Kjeldsen is a notable inventor based in Virum, Denmark, with a remarkable portfolio that includes 11 patents. His work has significantly contributed to the field of diabetes treatment, particularly through innovative insulin formulations.
Latest Patents
Kjeldsen's latest patents include groundbreaking developments in the realm of peptide-extended insulins and protease-stabilized insulin analogues. The peptide extended insulins involve insulins that are connected to an amino acid oligomer, providing satisfactory properties for diabetes management. In another inventive stride, he has developed protease-stabilized insulin analogues, which consist of mutations at specific positions in the insulin molecule to enhance resistance towards protease. This innovation also encompasses methods for preparing these insulin analogs and their application in diabetes mellitus treatment.
Career Highlights
Thomas Børglum Kjeldsen is currently affiliated with Novo Nordisk A/S, a leading global healthcare company specialized in diabetes care. Through his role, he has been heavily involved in advancing insulin therapies that improve the lives of individuals living with diabetes.
Collaborations
Throughout his career, Kjeldsen has collaborated with esteemed colleagues such as Peter Madsen and Tina Møller Tagmose. These collaborative efforts have further enriched the innovation landscape within Novo Nordisk, facilitating the development of impactful medical solutions.
Conclusion
Thomas Børglum Kjeldsen is a distinguished inventor whose contributions to insulin innovation continue to shape diabetes treatment. With his impressive patent portfolio and collaborations within a leading healthcare company, he remains a key figure in advancing medical research and solutions.